(Q40396482)

20 September 2017

1 reference

title

The interferons: biological effects, mechanisms of action, and use in multiple sclerosis (English)

1 reference

20 September 2017

0 references

Bianca Weinstock-Guttman

series ordinal

1

object named as

Weinstock-Guttman B

1 reference

20 September 2017

Ransohoff RM

2

1 reference

20 September 2017

Kinkel RP

series ordinal

3

1 reference

20 September 2017

Rudick RA

series ordinal

4

1 reference

20 September 2017

1 January 1995

1 reference

20 September 2017

1 reference

20 September 2017

37

1 reference

20 September 2017

7-15

1 reference

20 September 2017

1

1 reference

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

20 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370105

Posttranscriptional control of human gamma interferon gene expression in transfected mouse fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370105

A double-stranded RNA-inducible fish gene homologous to the murine influenza virus resistance gene Mx

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370105

Autoimmune disease and T-cell immunologic recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370105

Intrathecally administered natural human fibroblast interferon reduces exacerbations of multiple sclerosis. Results of a multicenter, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370105

Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370105

Persistent neurotoxicity of systemically administered interferon-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370105

21 January 2018

Identifiers

DOI

10.1002/ANA.410370105

1 reference

release_aytxh2js2jdsnndox5r7xd4p2a

20 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/aytxh2js2jdsnndox5r7xd4p2a

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference